跳至主要内容
临床试验/NCT05542797
NCT05542797尚未招募4 期

Comparison of Dydrogesterone and Micronized Progesterone Treatments in the Treatment of Threatened Miscarriage.

Konya Meram State Hospital0 个研究点目标入组 140 人开始时间: 2022年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
尚未招募
入组人数
140
主要终点
Miscarriage rate

研究概览

简要总结

In this study, we aimed to compare the effects of two drugs used for the threated miscarriage on the miscarriage rate.

详细描述

About 140 pregnant women who applied to our clinic due to the threated miscarriage in the first trimester will be randomly given micronized progesterone to half and dydrogesterone to the other half. After the treatment, the miscarriage rates in the groups will be compared.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 30 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • pregnant women with threated miscarriage in the first trimester.

排除标准

  • - pregnant women with abortus incipiens.

研究组 & 干预措施

Micronised progesterone

Experimental

Micronized progesterone will be given to 70 pregnant women with threated miscarriage.

干预措施: Duphastone (Drug)

Dydrogesterone

Experimental

Dydrogesterone will be given to 70 pregnant women with threated miscarriage.

干预措施: Duphastone (Drug)

结局指标

主要结局

Miscarriage rate

时间窗: One year

Effects of two drugs to be used on live birth rate in pregnant women with threated miscarriage

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hasan Ali Inal, MD

obstetrics and gynecology

Konya Meram State Hospital

相似试验